Zobrazeno 1 - 10
of 14
pro vyhledávání: '"S. L. Primo-Parmo"'
Autor:
Robert C. Sorenson, Bert N. La Du, S. L. Primo-Parmo, Theodore J. Standiford, Scott S. Billecke, Mohamad Navab, Michael Aviram
Publikováno v:
Chemico-Biological Interactions. :379-388
In recent years several lines of evidence have indicated that serum paraoxonase (PON1), and perhaps other mammalian paraoxonases, act as important guardians against cellular damage from toxic agents, such as organophosphates, oxidized lipids in the p
Autor:
S. L. Primo-Parmo, Michael Aviram, Charles L. Bisgaier, Mira Rosenblat, Roger S. Newton, B N La Du
Publikováno v:
Journal of Clinical Investigation. 101:1581-1590
HDL levels are inversely related to the risk of developing atherosclerosis. In serum, paraoxonase (PON) is associated with HDL, and was shown to inhibit LDL oxidation. Whether PON also protects HDL from oxidation is un- known, and was determined in t
Publikováno v:
Pharmacogenetics. 7:27-34
An unstable variant of human butyrylcholinesterase (BChE) is described in four apparently unrelated individuals sensitive to succinylcholine. Sequencing of genomic DNA revealed a single nucleotide substitution which results in the replacement of amin
Autor:
J.A. Doorn, S. L. Primo-Parmo, C.S. Dunlop, Scott S. Billecke, Clarence A. Broomfield, B N La Du
Publikováno v:
Chemico-biological interactions.
A novel mouse liver soluble fraction DFPase which has organophosphatase activities with sarin, soman and tabun, was purified and characterized. However, it lacks paraoxonase and arylesterase activities with paraoxon and phenyl acetate, respectively.
Publikováno v:
Genomics. 33(3)
A physiological role for paraoxonase (PON1) is still uncertain, but it catalyzes the hydrolysis of toxic organophosphates. Evidence that the human genome contains two PON1-like genes, designated PON2 and PON3, is presented here. Human PON1 and PON2 e
Publikováno v:
American journal of human genetics. 58(1)
The silent phenotype of human butyrylcholinesterase (BChE), present in most human populations in frequencies of approximately 1/100,000, is characterized by the complete absence of BChE activity or by activity
Publikováno v:
Genomics. 30(3)
The physiological role of mammalian paraoxonase/arylesterase is unknown. However, paraoxonase is an HDL-associated protein, and recent studies indicate that it may have anti-atherogenic functions. We describe the chromosomal localization and structur
Autor:
Oksana Lockridge, B N La Du, Robert C. Sorenson, Steve Adkins, S. L. Primo-Parmo, Chung-Liang Kuo
For three decades, mammalian paraoxonase (A-esterase, aromatic esterase, arylesterase; PON, EC 3.1.8.1) has been thought to be a cysteine esterase demonstrating structural and mechanistic homologies with the serine esterases (cholinesterases and carb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6c274cfb648b5a1b13b5e1c849983e5
https://europepmc.org/articles/PMC41304/
https://europepmc.org/articles/PMC41304/
Publikováno v:
Anesthesia and analgesia. 81(2)
Autor:
Eleidi A. Chautard-Freire-Maia, Muriel M. Vieira, Geraldo Picheth, S. L. Primo-Parmo, Cyntia M.T. Fadel-Picheth
Publikováno v:
Biochemical genetics. 32(3-4)
An improved method for the identification of butyrylcholinesterase phenotypes is proposed. It is based on modifications of a method that uses alpha-naphthyl acetate as substrate and DL-propranolol and Ro2-0683 as inhibitors. The proposed modification